drugset / Press release
Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses
2012-05-17 · Emergent BioSolutions · original emergentbiosolutions.com ↗
051712 - BioThrax Primary Series Approval FINAL.pdf 139.4 KB
The release as fetched from its publisher. emergentbiosolutions.com ↗